Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV–HCV co-infected patients on HCV therapy☆
To access this article, please choose from the options below
☆ The authors who have taken part in this study declared that they have no relationship with the manufacturers of the drugs involved and did not receive funding from industry to carry out this study.
PII: S0168-8278(08)00429-7
doi:10.1016/j.jhep.2008.06.024
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
